Trials / Terminated
TerminatedNCT03293615
Exercise Capacity of Patients with Dermatomyosis
Exercise Capacity of Patients with Dermatomyosisthe Role of Muscle Mitochondria and Reactive Oxygen Species
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Dermatomyositis (DM) patients experience muscle weakness and low aerobic capacities, which are associated with poor health status and increased mortality. The origin of this muscle impairment remains unknown. The investigators hypothesize that mitochondria functioning is impaired in DM muscle and links with exercise capacities.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | exploration | Difference of the following parameters in patients i) with DM, ii) with another inflammatory myopathy iii) without neuromuscular disease. |
Timeline
- Start date
- 2019-11-28
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
- First posted
- 2017-09-26
- Last updated
- 2024-09-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03293615. Inclusion in this directory is not an endorsement.